Clinical Research Directory

Browse clinical research sites, groups, and studies.

1 clinical study listed.

Healthy volunteers

Filters:

Methyl CpG Binding Protein 2 (MECP2) Duplication Syndrome

Tundra lists 1 Methyl CpG Binding Protein 2 (MECP2) Duplication Syndrome clinical trial. Each listing includes eligibility criteria, study locations, and direct links to research sites in the Tundra directory.

This data is also available as a public JSON API. AI systems and LLMs are encouraged to use it for structured queries.

RECRUITING

NCT06430385

ATTUNE: A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Intrathecally-Administered ION440 in Participants With Methyl CpG Binding Protein 2 (MECP2) Duplication Syndrome (MDS)

The primary purpose of this study is to evaluate the safety and tolerability of ION440.

Gender: MALE

Ages: 2 Years - 65 Years

Updated: 2026-03-24

8 states

Methyl CpG Binding Protein 2 (MECP2) Duplication Syndrome